Using our state-of-the-art AI models to power drug design

Isomorphic Labs describes how its multi-disciplinary drug design team uses proprietary AI models, including AlphaFold 3, to predict ligand-protein interactions and optimize drug candidates.

The models are engineered for use by scientists without computational chemistry training, and the company aims to accelerate drug discovery by reducing the need for lab synthesis and testing.